高级检索
当前位置: 首页 > 详情页

Occult pancreaticobiliary reflux is a pathogenic factor of some benign biliary diseases and gallbladder cancer

| 导出 | |

文献详情

资源类型:
WOS体系:
Pubmed体系:

收录情况: ◇ SCIE ◇ CSCD-C ◇ 卓越:梯队期刊

单位: [1]Huazhong Univ Sci & Technol, Tongji Hosp, Tongji Med Coll, Dept Organ Transplantat, Wuhan 430000, Peoples R China [2]Chinese Acad Med Sci, Key Lab Organ Transplantat, Minist Educ, Wuhan 430000, Peoples R China [3]Chinese Acad Med Sci, NHC Key Lab Organ Transplantat, Wuhan 430000, Peoples R China [4]Chinese Acad Med Sci, Key Lab Organ Transplantat, Wuhan 430000, Peoples R China [5]Huazhong Univ Sci & Technol, Tongji Hosp, Tongji Med Coll, Dept Biliopancreat Surg, Wuhan 430000, Peoples R China
出处:
ISSN:

关键词: Occult pancreaticobiliary reflux Biliary diseases Bile amylase Pancreaticobiliary junction Gallbladder cancer

摘要:
Background: Pancreaticobiliary maljunction (PBM) is a well-known high-risk factor for biliary malignant tumors because of constant pancreaticobiliary reflux (PBR). However, the impact of occult pancreatico-biliary reflux (OPR), which is characterized by high bile amylase levels in individuals with anatomically normal pancreaticobiliary junction, on biliary diseases remains unclear. The aim of this study was to as-sess the correlation between OPR and biliary diseases.Methods: We enrolled 94 consecutive patients with normal pancreaticobiliary junction and primary bil-iary diseases confirmed by magnetic resonance cholangiopancreatography. We prospectively collected pa-tients' bile samples and measured bile amylase levels. We investigated the incidence of OPR and the difference in bile amylase levels among these patients and assessed the correlation between high bile amylase levels (HBAL) and benign or malignant biliary diseases, as well as the OPR risk factors.Results: The incidence of OPR was 36.6% in patients with benign biliary diseases, 26.7% in those with cholangiocarcinoma and 62.5% in those with gallbladder cancer. The median bile amylase level tended to be higher in patients with gallbladder cancer than in those with benign biliary diseases, but there was no significant difference (165.5 IU/L vs. 23.0 IU/L, P = 0.212). The prevalence of an HBAL with bile amylase levels of 10 0 0-750 0 IU/L was similar in patients with gallbladder cancer and benign biliary diseases. However, the incidence of HBAL with bile amylase levels greater than 7500 IU/L was significantly higher in patients with gallbladder cancer than in those with benign biliary diseases (37.5% vs. 4.2%, P = 0.012). Multivariate logistic regression analysis revealed that choledocholithiasis was an independent risk factor for OPR.Conclusions: OPR can occur in benign and malignant biliary diseases, and it may be a pathogenic fac-tor for some benign biliary diseases and a high-risk factor for gallbladder cancer. There is a correlation between choledocholithiasis and OPR.(c) 2022 First Affiliated Hospital, Zhejiang University School of Medicine in China. Published by Elsevier B.V. All rights reserved.

语种:
被引次数:
WOS:
PubmedID:
中科院(CAS)分区:
出版当年[2022]版:
大类 | 3 区 医学
小类 | 3 区 胃肠肝病学
最新[2025]版:
大类 | 3 区 医学
小类 | 4 区 胃肠肝病学
JCR分区:
出版当年[2021]版:
Q3 GASTROENTEROLOGY & HEPATOLOGY
最新[2023]版:
Q2 GASTROENTEROLOGY & HEPATOLOGY

影响因子: 最新[2023版] 最新五年平均 出版当年[2021版] 出版当年五年平均 出版前一年[2020版] 出版后一年[2022版]

第一作者:
第一作者单位: [1]Huazhong Univ Sci & Technol, Tongji Hosp, Tongji Med Coll, Dept Organ Transplantat, Wuhan 430000, Peoples R China [2]Chinese Acad Med Sci, Key Lab Organ Transplantat, Minist Educ, Wuhan 430000, Peoples R China [3]Chinese Acad Med Sci, NHC Key Lab Organ Transplantat, Wuhan 430000, Peoples R China [4]Chinese Acad Med Sci, Key Lab Organ Transplantat, Wuhan 430000, Peoples R China
通讯作者:
推荐引用方式(GB/T 7714):
APA:
MLA:

资源点击量:589 今日访问量:0 总访问量:441 更新日期:2025-06-01 建议使用谷歌、火狐浏览器 常见问题

版权所有:重庆聚合科技有限公司 渝ICP备12007440号-3 地址:重庆市两江新区泰山大道西段8号坤恩国际商务中心16层(401121)